Limited Source Justification - Tamiflu 30mg & 75mg capsules
Awarded Limited / Sole Source Justification Posted
See the award notice from .
- Solicitation number
- 75A50324F80002
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D0219-75A50324F80002 Federal contract award
- Awardee
- Genentech Usa, Inc.
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- South San Francisco, California 94080, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response published a Limited Source Justification Notice to procure 500,000 treatment courses of Tamiflu 30mg and 75mg capsules on a sole source basis from Roche Laboratories Inc. The department requires the Tamiflu capsules to maintain in the Strategic National Stockpile for potential pandemic influenza outbreaks or other public health emergencies. As Roche Laboratories Inc. is the only manufacturer approved by the Food and Drug Administration to produce and distribute Tamiflu capsules in the United States, the department determined a limited competition procurement from Roche was justified given it is the only responsible source and pricing is reasonable based on prior contract pricing for the same supplies.
Notice text
The Administration for Strategic Preparedness and Response, Division of Strategic National Stockpile (DSNS) awarded a brand name Firm Fixed Priced delivery order to Genentech USA, Inc., located at 1 DNA Way, South San Francisco, CA 94080-4918. This delivery order was awarded under the authority of a Limited Source Justification pursuant to FAR 8.405-6(b), Item peculiar to one manufacturer – brand name product for Tamiflu oseltamivir.
The delivery order was awarded to supplement the national strategic stockpile of influenza antivirals, specifically, 75mg strength and 30mg strength of brand name Tamiflu oseltamivir. Influenza, commonly known as the flu, is a highly contagious and severe infectious disease that poses a significant threat to public health.
Awarded contract 36F79723D0219 to unknown vendor for unknown amount on 2023-11-17.
Files
| File | Type | Posted |
|---|---|---|
| LSJ Tamiflu 30mg and 75mg_Final_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Tamiflu 75mg & 30mg - LSJ | Limited / Sole Source Justification | |
| Tamiflu 75mg & 30mg - Award Notice | Award Notice | |
| This notice | Limited / Sole Source Justification |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity